Aura Biosciences, Inc. (AURA)
NASDAQ: AURA · Real-Time Price · USD
6.92
-0.06 (-0.86%)
Nov 20, 2026, 2:03 PM EST - Market open
Aura Biosciences Stock Forecast
Stock Price Forecast
According to 6 analysts polled by S&P Global, Aura Biosciences stock has a consensus rating of "Strong Buy" and an average price target of $16.6. The average 1-year stock price forecast is 139.88% higher than the current stock price, while the lowest is $12 (+73.41%) and the highest is $23 (+232.37%).
Price Target: $16.6 (+139.88%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Aura Biosciences stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Apr '26 | May '26 | Jun '26 | Jul '26 | Aug '26 | Nov '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 5 | 5 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 6 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $18 | Buy | Reiterates | $18 | +160.12% | Nov 9, 2026 |
| LifeSci Capital | LifeSci Capital | Buy Maintains $23 | Buy | Maintains | $23 | +232.37% | Aug 12, 2026 |
| Leerink Partners | Leerink Partners | Buy Reiterates n/a | Buy | Reiterates | n/a | n/a | Jun 2, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
4.93M
EPS This Year
n/a
EPS Next Year
n/a